In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly ...

Market participants expect Sybos to make a total exit from Ebos when escrow arrangements expire as it is diversifying away ...

Sybos Holdings, a unit of Zuellig Group, said it had entered into a block trade agreement with a financial institution to ...

The New Zealand sharemarket fell on Thursday after one of the largest investors in Ebos Group sold a significant number of ...

Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand: Bangkok, Thailand Thursday, May 29, 2025, 11:00 Hrs [IST] Zuellig Pharma, a ...

Medical product wholesaler and distributor EBOS has seen its share price sink after it confirmed major shareholder Sybos will ...

UBS launched a $NZ950 million ($880 million) block trade in EBOS Group after-market on Wednesday on behalf of major ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounja ...

Thai patients gain faster access to next-generation treatments as Zuellig and Lilly deepen their healthcare partnership.

John Graham, Group CEO of Zuellig Pharma, shares how big pharmaceutical companies are taking steps to mitigate the fallout from new U.S. tariffs. RFK Jr. Calls Out King Abdullah: ‘They’ve Cut ...

Zuellig Pharma, a leading healthcare solutions company, has been appointed as the exclusive distribution partner of STADA Philippines Inc., a fast-growing supplier of high-quality pharmaceuticals and ...